IBI188 Combination Therapy in Solid Tumors
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Lung Adenocarcinoma
- Osteosarcoma
- Solid Tumors
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: Non-RandomizedIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 12 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04861948
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Ba Yi Tianjin Medical University Cancer Institute and Hospital Principal Investigator: Zhang Dahong Zhejiang Provincial People's Hospital Principal Investigator: Guo Hongqian The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School Principal Investigator: Fang Meiyu Zhejiang Cancer Hospital Principal Investigator: Xie Yu Hunan Cancer Hospital Principal Investigator: Liu Jisheng First Affiliated Hospital of Soochow University Principal Investigator: Wang Ying Zhejiang Provincial People's Hospital Principal Investigator: Wang Haiying Shougang Hospital, Peking University Principal Investigator: Wang Mengzhao Shougang Hospital, Peking University Principal Investigator: Lv Qiang Jiangsu Provincial People's Hospital Principal Investigator: Li Xiangping Nanfang Hospital of Southern Medical University Principal Investigator: Liu Guihong Affiliated Hospital of Xuzhou Medical University Principal Investigator: Mou Weiqi Chongqing University Cancer Hospital Principal Investigator: Guo Wei Peking Union Medical College Principal Investigator: Wang Wei Hunan Cancer Hospital Principal Investigator: Xu Chongyuan Nanfang Hospital of Southern Medical University
Get Well Soon